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ChIP-seqThroughout evolution, DNA transposons provide a recurrent supply of genetic information to give rise to
novel gene functions by fusion of their transposase domain to various domains of host-encoded proteins.
One of these ‘‘domesticated”, transposase-derived factors is SETMAR/Metnase which is a naturally
occurring fusion protein that consists of a histone-lysine methyltransferase domain and an HsMar1
transposase. To elucidate the biological role of SETMAR, it is crucial to identify genomic targets to which
SETMAR specifically binds and link these sites to the regulation of gene expression. Herein, we mapped
the genomic landscape of SETMAR binding in a near-haploid human leukemia cell line (HAP1) in order to
identify on-target and off-target binding sites at high resolution and to elucidate their role in terms of
gene expression. Our analysis revealed a perfect correlation between SETMAR and inverted terminal
repeats (ITRs) of HsMar1 transposon remnants, which are considered as natural target sites for
SETMAR binding. However, we did not detect any untargeted events at non-ITR sequences, calling into
question previously proposed off-target binding sites. We identified sequence fidelity of the ITR motif
as a key factor for determining the binding affinity of SETMAR for chromosomes, as higher conservation
of ITR sequences resulted in increased affinity for chromatin and stronger repression of SETMAR-bound
gene loci. These associations highlight how SETMAR’s chromatin binding fine-tune gene regulatory net-
works in human tumour cells.
 2021 The Author(s). Published by Elsevier B.V. on behalf of Research Network of Computational and
Structural Biotechnology. This is an open access article under the CC BY license (http://creativecommons.
org/licenses/by/4.0/).1. Introduction
Transposons of the mariner family are present in a wide variety
of eukaryotic genomes, including humans [1–3]. These transposons
contain a single gene encoding the transposase, flanked by short,
<30-bp inverted terminal repeat (ITR) sequences.Mariner elements
mobilize through a cut-and-paste mechanism catalyzed by the
transposase, which belongs to a large family of recombinase pro-
teins including retroviral/retrotransposon integrases and trans-
posases, characterized by the DDE/D signature in the catalyticdomain of the proteins [2,3]. Transposition results in the accumu-
lation of hundreds or thousands of transposon copies over evolu-
tionary time. However, most mariner copies appear to be dead
remnants of once active transposons inactivated by mutations [4].
Mariner elements are represented by two subfamilies in the
human genome: Hsmar1 [5] and Hsmar2 [6]. The first Hsmar1 ele-
ment entered the primate genome lineage approximately 50 mil-
lion years (Myr) ago, and transposition was ongoing until at least
37 Myr ago, producing 114 ‘‘full-length” Hsmar1 copies [5]
(Fig. 1. However, none of the present copies encodes a functional
transposase protein due to mutational inactivation. The Hsmar1
transposon copies are accompanied by 42 ‘‘gappy” Hsmar1 ele-
ments containing internal deletions in their transposase coding
sequences, 5252 copies of solo-ITRs (containing a single ITR) and
2679 copies of an Hsmar1-related, paired-ITR element, MADE1
Fig. 1. Characteristics of Hsmar1 mariner transposons. ‘‘Full-length” Hsmar1, ‘‘gappy” Hsmar1, and MITEs (Miniature Inverted Repeat Transposable Elements) contain two
inverted terminal repeat (ITR) sequences (red triangles). ‘‘Solo” inverted repeats contain one ITR linked to a truncated Hsmar1 sequence or not. In each category, up to three
mismatches were allowed in the flanking ITR sequences (‘‘core” motif: 5’-GGTGCAAAAGTAATTGCGG-3’). Histogram shows the length distribution of MITE sequences with a
median size of 68 bp. Only ITRs within 500 bp were considered to identify MITEs. The number of cases (n) is shown on the left. (For interpretation of the references to colour in
this figure legend, the reader is referred to the web version of this article.)
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ments (MITEs) are thought to have been generated by internal
deletions of longer transposons (median MADE1 length: 68 bp,
Fig. 1); they make up the predominant fraction of DNA elements
in flowering plants, and are often found in animal genomes [8].
Despite their parasitic nature, there is increasing evidence that
transposable elements are a powerful force in gene evolution.
Indeed, about 50 human genes are derived from transposable ele-
ments [7], among them genes that are responsible for
immunoglobulin gene recombination in all vertebrates [9]. One
of these ‘‘domesticated”, transposase-derived genes is SETMAR
(also called Metnase), a fusion gene containing an N-terminal SET
domain fused in-frame to an Hsmar1 transposase [5,10]. The SET-
MAR gene has apparently been under selection; the transposase
open reading frame is conserved, and shows only 2.4% divergence
from a consensus Hsmar1 transposase gene sequence (vs. 8% aver-
age divergence between Hsmar1 transposase genes) [5]. The SET
domain can be found in histone methyltransferases that regulate
gene expression by chromatin modifications [11]. Accordingly,
the SETMAR protein has been shown to methylate histone H3 lysi-
nes 4 and 36 in vitro, and has been proposed to play a role in DNA
double-strand break (DSB) repair [12].
The cellular function(s) of SETMAR remain enigmatic. Cordaux
et al. have found that selection has been preserving the ITR-
binding activity of SETMAR [10]. Accordingly, both the transposase
domain of SETMAR as well as the full-length SETMAR protein were
shown to bind to Hsmar1 ITR sequences in vitro [10]. Thus, a func-
tion of the SETMAR protein is likely associated with its ability to
specifically recognize numerous genomic binding sites represented
by the Hsmar1 ITRs. Through its ability to bind to Hsmar1 trans-
poson ITR sequences, and to catalyze specific histone modifications
[12], SETMAR could contribute to transcriptional gene regulation
by inducing targeted chromatin modifications. Indeed, mariner
transposase domains were recently described to have a propensity
to undergo domestication by recurrent fusion to host transcrip-
tional regulatory domains, especially the Krüppel-associated box
(KRAB) domain; these KRAB-transposase fusion proteins repress
gene expression in a sequence-specific fashion [13].
SETMAR is broadly expressed in human tissues (Supplementary
Fig. S1) and cell lines (Supplementary Fig. S2), suggesting a4033housekeeping function [12]. In addition, transcriptional variants
of SETMAR show a broad expression pattern in human diseases
including cancer [14–16]. Overexpression of SETMAR is favourable
in kidney cancer and unfavourable in liver cancer, while most
TCGA cancers have no significant survival association with SET-
MAR (https://www.proteinatlas.org/ENSG00000170364-
SETMAR/pathology). Molecular explanation for these heteroge-
neous relationships is still unknown. To elucidate the pro- and
anti-tumorigenic activities of SETMAR in a mechanistic detail, it
is crucial to identify genomic targets to which SETMAR specifically
binds in cancer cells and link these sites to the regulation of gene
expression. A recent study used the ChIP-exo approach to map
Flag-tagged SETMAR binding sites in the hyper-aneuploid U2O2
osteosarcoma cell line [17], which allowed the first evaluation of
SETMAR cistrome in human tumour cells. However, the majority
of ChIP-exo peaks (69%  605 out of 875) could not be enriched
at the expected target ITRs of the Hsmar1 transposons, which are
considered as natural landing sites for SETMAR chromosome bind-
ing. Significant off-target binding have been reported in another
(unpublished) study [18], but the reason for SETMAR’s non-ITR
binding remained unexplained. We therefore decided to map the
genomic landscape of SETMAR in a near-haploid human leukemia
cell line (HAP1) to identify on-target and off-target binding sites at
high resolution and to elucidate their role in terms of gene expres-
sion. Our analysis revealed a perfect correlation between SETMAR
and ITR sequences without any untargeted events, calling into
question the previously proposed off-target regions. In addition,
we identified ITR sequence conservation as a key factor for deter-
mining the affinity of SETMAR for chromosomes.
2. Materials and methods
2.1. Cell line and plasmids
The HAP1 cell line were maintained in complete Iscove’s Mod-
ified Dulbecco’s Medium (IMDM, Sigma) supplemented with 10%
heat inactivated Tetracycline free Foetal Bovine Serum (iBiotech),
1% penicillin/ streptomycin (Sigma) at 37 C with 5% CO2. The SET-
MAR knockout cell line was generated by the CRISPR/Cas9 technol-
ogy. The CCTGATCATGTAGTTGGACC gRNA sequence was designed
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exon of the SETMAR gene (chr3 4,312,904 (hg38), transcript:
NM_006515). The mutated cells harbour a 10 bp deletion at the
target site, which resulted in a frame shift and a premature stop
codon 30 bp downstream to the cleavage locus. The generation
of the knockout cell line was performed by Horizon Genomics
(https://horizondiscovery.com/). The SETMAR knockout cell line
was made transgenic with the Sleeping Beauty (SB) technology to
express an N-terminally hemagglutinin (HA) tagged version of
the SETMAR protein as follows. The SB transposon donor was cre-
ated by blunt-end cloning the BamHI/XbaI fragment of pcDNA-HA/
SETMAR to the SalI/NotI site of the pTOV-T11-SV40puro [19].
500 ng of the resulting SB transposon donor plasmid, pTOV-HA-
SETMAR-puro, was co-transfected with 100 ng of pcGlobinSB100X
transposase expressing vector [20] with polyethylene imine into
the knockout HAP1 cells, which were subjected to 1 lg/ml puro-
mycin selection to obtain the polyclonal HA-SETMAR-expressing
cell line. The expression of the HA-SETMAR transgene and doxycy-
cline inducibility were verified with Western-blot analysis using
anti-HA antibody (11867423001, Roche).
2.2. SETMAR induction
pTOV-HA-SETMAR-puro was induced by increasing doxycycline
concentrations (0.2 mg/ml, 0.5 mg/ml, 1 mg/ml, 2 mg/ml) 24 h before
the ChIP measurement. The HA-tagged SETMAR protein is here-
inafter referred to as ‘‘SETMAR-HA” throughout the text. Expres-
sion levels were quantified by western blot and a concentration
of 0.5 mM doxycycline was selected for subsequent NGS (ChIP-
seq) experiments. For western blot, whole cell extracts were pre-
pared by RIPA Buffer (50 mM Tris pH8, 150 mM NaCl, 1%, NP-40,
0.5% sodium deoxycholate, 0.1% SDS) supplemented with protease
inhibitors (Pierce Protease Inhibitor Mini Tablets, Thermofisher
A32953) followed by sonication (Diagenode Bioruptor Plus; 1x5
cycles 30 sec on/off High mode). The extracts were prepared from
dox-treated (induced) and untreated (uninduced) cells at a concen-
tration of 107 cells/ml. After centrifugation at 15.000  g (at 4 C
for 20 min), protein concentrations were measured by the BCA
assay (Pierce BCA Protein Assay Reagent; Thermofisher 23225).
30 mg of protein extracts were run by SDS-PAGE (5–12%AA gel,
Bio-Rad MiniProtean) and transferred to nitrocellulose membranes
(Millipore, Billerica, MA). Ponceau S staining was used to quantify
the protein levels. Membranes were blocked with 1% BSA/PBST for
1 h and then incubated with a rabbit polyclonal anti-HA tag anti-
body (Abcam ab9110; 1:4000) and an anti-beta-actin mouse mon-
oclonal antibody (8H10D10, Invitrogen; 1:2000) at 4 C overnight,
with gentle shaking. A custom-made anti-SETMAR polyclonal anti-
body (ThermoFisher Scientific) was also used to detect
endogenous- and HA-tagged SETMAR, which was produced by
immunizing rabbits with the purified protein corresponding to
the C-terminal 135 amino acids of SETMAR. After three washes
in 1% BSA/PBST, secondary antibodies were added at room temper-
ature for 1 h: Alexa Fluor 647 goat anti-rabbit IgG (Invitrogen
1:1000, A-21245), and Alexa Fluor 680 Goat Anti-Mouse IgG
(1:1000, ab175775, Abcam). Fluorescent signals were detected by
the Molecular ImagerPharosFXTM system (Bio-Rad).
2.3. Chromatin immunoprecipitation and qPCR
2x107 cells were fixed by 1% formaldehyde (V = 20 ml) for
10 min at room temperature (in T175 flasks), and were then
quenched by 416 mM glycine for 5 min. After three washes in
ice cold PBS/T, cells were scraped off and pelleted by centrifugation
at 1000xg for 5 min at 4 C. Cell pellets were stored at 80 C. For
ChIP, 2x107 cells were suspended in 1.5 ml of ChIP Lysis Buffer
(50 mM HEPES-KOH pH 7.5, 140 mM NaCl, 1 mM EDTA pH8, 1%4034Triton X-100, 0.1% Sodium Deoxycholate, 1% SDS, supplemented
with protease inhibitors) and disrupted by Fast prep (speed: 6 m/
s; time: 40 sec; 2 cycles; pause time: 120 sec). Chromatin lysates
were sonicated in 1.5 ml LowBind tubes (600 ll sample/tube using
Diagenode Bioruptor Plus (2x5 cycles, 30 sec ON/OFF LOW). After
sonication, cell debris were pelleted by centrifugation at 16.000 g
(at 4 C for 20 min). Fragment length distribution of sonicated sam-
ples (50 ll) was checked by 1% agarose gel electrophoresis after
reverse crosslinking (at 65 C for 6 h) and phenol–chloroform
extraction. Immunoselection was performed by 100 ml DynabeadsTM
Protein G precoated with 8 mg of rabbit polyclonal anti-HA anti-
body (Abcam ab9110, ChIP-grade). 5% of sonicated chromatin
was saved as ‘‘input” while the rest (‘‘IP”) was diluted 1:10 with
IP Dilution Buffer (1% Triton X-100, 2 mM EDTA pH8, 20 mM
Tris-HCL pH 8, 150 mM NaCl, supplemented with protease inhibi-
tors) in 15 ml tubes and incubated with antibody-coated magnetic
beads (at 4 C overnight, with rotation). Beads were washed twice
in low salt wash buffer (0.1 % SDS; 1% Triton X 100; 2 mM EDTA;
20 mM Tris-HCl; 150 mM NaCl), high salt wash buffer (0.1% SDS;
1 % Triton X 100; 2 mM EDTA; 20 mM Tris-HCl; 500 mM NaCl), LiCl
wash buffer (0.25 M LiCl; 1% NP40; 1% Na-deoxicolate; 1 mM
EDTA; 10 mM Tris-HCl) and in TE buffer (10 mM Tris-HCl, 1 mM
EDTA) at 4 C for 1 min, using MagnaRack. IP and input samples
were then eluted in 100ul elution buffer (0.1 M NaHCO3, 1% SDS)
for 15 min at 30 C with frequent vortexing. Supernatants were
transferred to LoBind Eppendorf tubes and stored at 80 C. Vali-
dation of SETMAR-HA binding sites (predicted by ChIP-seq analy-
sis, see below) were performed by real-time quantitative PCR
(qPCR) using a QuantStudio12KFlex machine (Applied Biosys-
temsTM) and LightCycler 480 SYBR Green I Master (Roche) PCR
reagent, following the manufacturer recommendations. Measure-
ments were done in triplicates from two independent biological
replicate experiments, and enrichment ratios were plotted as ‘‘per-
cent of input”, corrected for dilution. qPCR primers are listed in
Supplementary Table S1.2.4. Illumina sequencing and bioinformatic analysis
NGS libraries were prepared by the Nugen Ovation Ultralow
System V2 library preparation kit (NuGEN Technologies) following
the manufacturer’s instructions. 241 million reads were sequenced
(paired-end) from two independent biological replicate experi-
ments using an Illumina Nextseq 500 machine and the NextSeq
500/550 Mid Output Kit v2 (Illumina). 97.31% of reads were
mapped on the GRCh38 (hg38) human reference genome by Bow-
tie2 version 2.3.4.1 [21] using default parameters. Picard was used
to remove PCR duplicates from BAM files created by Samtools ver-
sion 1.10 [22], applying default parameters. Repetitive segments of
the genome were blacklist filtered (according to 05.05.2020, Stan-
ford University, Anshul Kundaje Lab) and BAM files containing 185
million mapped reads were RPKM normalised using deeptools ver-
sion 3.3.1 [23] applying bamCoverage processing (bin
size = 100 bp; smooth length = 300 bp). MACS2 version 2.2.6
[24] was used to identify ChIP peaks from bedGraph files, applying
default parameters. IP and corresponding Input data were pro-
cessed in parallel. Peaks identified in Input were filtered out from
IP samples using Bedtools version 2.29.0 [25]. Eleven ChIP peaks
fell into unmappable segments of the hg38 reference genome
and were therefore excluded from further analysis. Computer ran-
domized peak sets were generated by Bedtools as a null model for
significance tests. Blacklisted regions were excluded from random
peak set generation. Annotation of SETMAR-HA chromosomal
binding sites was performed according to the genomic categories
of HOMER [26]. Peaks (observed and random) were extended by
+/- 500 bp and their overlap ratios were determined with the
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summits were considered (peak sizes were not extended).
De novo SETMAR-HA binding motifs were identified by the
MEME Suite version 5.3.0 [27] using the MEME and MAST tools.
The motifs are listed in Supplementary Table S1 (MEME MAST
worksheet). 763 SETMAR peaks contain the ITR consensus
sequence GGTGCAAAAGTAATTGCGG identified by Cordeux R
et al. [10] as an in vitro binding site for SETMAR. In parallel, we
mapped the ITR consensus sequence by Cordeux R et al. [10] on
the hg38 reference genome using Biostring and BSgenome.Hsapi-
ens.UCSC.hg38 (R project) allowing 0–3 mismatches, and anno-
tated the sequences based on the number of mismatches (0-
3MM ITR groups; Supplementary Table S1 ‘‘ITR_10854” sheet and
MEME MAST sheet). The overlap of annotated ITRs and SETMAR-
HA ChIP peaks (extended by +/- 500 bp) are shown in Figs. 4 and
5. Statistical analysis was performed and plots were generated by
R version 3.6.3 (2020–02-29). Heatmaps and pileup plots were cre-
ated by deepTools. NGS tracks were visualized by Integrative Gen-
ome Browser (IGV) version 2.8.4 [28] and JBrowse [29]. Published
genomic datasets used in our analysis: RNA-seq (SRR5266566
(GSM2493886), SRR5266578 (GSM2493898) [30], ChIP-exo
(GSE108773, [17]). SRA files were converted to fastq files by
fastq-dump (version 2.10.4) using default parameters. RNA-seq
reads were aligned to the hg38 genome by TopHat (version
v2.1.1) [31] and FPKM values (Fragments Per Kilobase of transcript
per Million mapped reads) were calculated by Cufflinks (version
v2.2.1) [32].Fig. 2. Experimental design. (A) Scheme of SETMAR gene deletion and integration of the
various tetracycline (TET) concentrations. Tet-treatment was performed for 24 h. Upp
Quantification of band intensities as a function of TET concentrations.
40353. Results and discussion
Tomap the chromatin binding sites of SETMARwith high spatial
resolution, we set up an experimental system in the nearly haploid
HAP1 lymphoblastoid leukaemia cell line [33] in which the endoge-
nous SETMAR locus was knocked out by CRISPR/Cas9 technology
followed by complementation by a doxycycline-inducible isoform
of SETMAR carrying an N-terminal hemagglutinin tag (pTOV-
HA-SETMAR-puro, Fig. 2A). The haploid chromosome set allows
us to maximize NGS resolution and peak calling accuracy, while
knockout of the parental allele is expected to prevent competition
between endogenous and epitope-tagged SETMAR isoforms during
chromatin binding. Western blot analysis shows that the kinetics of
SETMAR-HA induction linearly scaled with the dose of dox concen-
tration, while the tagged protein was not expressed in the absence
of drug treatment (Fig. 2B) or in wild-type HAP1 cells (Supplemen-
tary Fig. S3A). The amount of SETMAR-HA at a dox concentration of
0.5 lg/ml was about 3–4 times the amount of endogenous SETMAR
expressed in wild-type HAP1 cells (detected by an anti-SETMAR
antibody; Supplementary Fig. S3B), which provided optimal
enrichment for ChIP experiments without significant overexpres-
sion of the fusion protein. The observed increase in SETMAR expres-
sion levels falls well within the physiological range of SETMAR
expression detected in various human tissues and cell lines
(Supplementary Fig. S1-S2), which show approximately 80-fold
differences. Of the 241 million sequenced reads, we identified





























conditional allele (pTOV-HA-SETMAR-puro). (B) Kinetics of SETMAR-HA induction at
er panel: western blot with anti-HA and anti-beta Actin antibodies. Lower panel:
Fig. 3. Genome-wide mapping of SETMAR binding sites by ChIP-seq. Upper panel: Genome browser track showing the chromosomal distribution of ChIP peaks (vertical
blue bars). Lower panel: Validation of representative SETMAR-HA binding sites from different chromosomes by ChIP-qPCR. Positive and negative sites are highlighted in red
and grey, respectively. Position of PCR amplicons and ChIP peak summits are shown below the IGV tracks. (For interpretation of the references to colour in this figure legend,
the reader is referred to the web version of this article.)
Fig. 4. Annotation of SETMAR-HA binding sites in the human genome. (A) Association of ChIP peaks with genic (exon, intron, TSS, TTS) and intergenic regions. TSS:
transcription start site. TTS: transcription termination site. Left and right panels: observed and expected (computer randomized) distributions, respectively. Number of peaks:
764. (B) Detailed annotation of ChIP peaks over 11 functional genomic categories. n: number of elements in categories. Cells contain observed / expected ratios for peak
counts. Warmer colours represent higher enrichment. Statistically significant enrichment is observed at TSS (p-value = 0.03), MADE1 (p-value < 2.2  10-16) and ITR regions
(p-value < 2.2  10-16; prop. z test; level of significance: 0.05).
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Fig. 5. SETMAR-HA preferentially binds to inverted terminal repeat (ITR) sequences. (A) Genome browser track showing the distribution of SETMAR-HA ChIP peaks (blue)
and ITR motifs (green) for each autosome and the sex chromosome (chrX). (B) The summit of SETMAR-HA signal perfectly coincides with ITRs (red curve and heatmap). The
ChIP signal is depleted over random sites (yellow, green, and blue curves). (C) Upper panel: Proportional Venn diagram showing the overlap of SETMAR ChIP peaks and ITR
motifs. Of the 764 SETMAR-HA peaks, 763 sites (99.9%) are associated with ITRs. Of the 10,854 ITRs, 1227 motifs (11.3%) are localized in SETMAR-HA peaks. Lower panel:
Chromosomal distribution of SETMAR-HA binding sites and ITR motifs is strongly correlated. The number of SETMAR-HA peaks and ITRs were plotted as a function of
chromosome length. They show significant covariation and correlation with chromosome length (Spearman r = 0.89; p < 0.001). Dots: chromosomes. Chromosome X rep-
resents an outlier in terms of ChIP peak numbers. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Table 1
Functional annotation of SETMAR-associated genes (n = 288). Upper table: top five hits of GO-term analysis. Lower table: list of
significant MAPK genes.
#term ID term description observed gene count background gene count FDR
hsa04010 MAPK signaling pathway 14 293 0.0143
IPR000742 EGF-like domain 15 225 0.0016
GO:0005515 Protein binding 128 6607 0.0409
KW-0597 Phosphoprotein 161 8067 1.90E-05
KW-0025 Alternative splicing 203 10,225 1.13E-08
Gene name Ensemble ID Function
ANGPT1 ENSG00000154188 angiopoietin 1
CACNA1A ENSG00000141837 calcium voltage-gated channel subunit alpha1 A
CACNA2D1 ENSG00000153956 calcium voltage-gated channel auxiliary subunit alpha2delta 1
EFNA5 ENSG00000184349 ephrin A5
FGF1 ENSG00000113578 fibroblast growth factor 1
NTRK2 ENSG00000148053 neurotrophic receptor tyrosine kinase 2
PAK2 ENSG00000180370 p21 (RAC1) activated kinase 2
PLA2G4C ENSG00000105499 phospholipase A2 group IVC
PRKACB ENSG00000142875 protein kinase cAMP-activated catalytic subunit beta
PRKCB ENSG00000166501 protein kinase C beta
SOS1 ENSG00000115904 SOS Ras/Rac guanine nucleotide exchange factor 1
STK3 ENSG00000104375 serine/threonine kinase 3
TGFA ENSG00000163235 transforming growth factor alpha
MAP3K20 ENSG00000091436 mitogen-activated protein kinase kinase kinase 20
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the 23 chromosomes except the mitochondrial genome (mtDNA),
which was used as an internal negative control. Representative
binding sites were validated by ChIP-qPCR measurements in dox-
treated and untreated samples (Fig. 3 and Supplementary
Fig. S4), confirming the specificity of our peak detection. We next4037analysed the overlap of SETMAR-HA binding sites with annotated
genomic categories of the hg38 reference genome (Fig. 4). Func-
tional annotation revealed that most SETMAR-HA sites were
located in intergenic regions (52%  398 peaks) and introns (43%
 329 peaks; Fig. 4A), however, the observed frequencies did not
differ from the expected (theoretical) distribution. Statistically sig-
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p = 0.03), MADE1 miniature transposons (p < 2.2  10–16), and
other, Hsmar1 transposon-derived ITR sequences (p < 2.2  10–16
; Fig. 4B). The number of peaks in TSS/promoter regions represented
only 4% of the binding sites (27 peaks), however, SETMAR-HA was
bound to 288 protein-coding genes when TSS-exon–intron-TTS
regions were considered (we note that there may be multiple peaks
within the same gene). GO-term analysis of SETMAR-associated
genes showed enrichment of the MAPK signalling pathway (sum-
marized in Table 1), suggesting a possible role for SETMAR in cell
cycle control. Indeed, overexpression of SETMAR significantly
reduced the proliferation rate of U2OS osteosarcoma cells [17], con-
sistent with this model. Regarding intergenic regions, all the iden-
tified peaks (398 sites) were located in ITR sequences (Fig. 5) or
MADE1 elements flanked by ITRs (Fig. 4B). Pileup and Venn diagram
analysis (Fig. 5B-C) highlights the perfect colocalization between
peak summits and ITR motifs within genic and intergenic regions.
We note, however, that only a subset of ITRs were accessible for
SETMAR binding (1227 motifs  11.3%), which is still significant
compared to a randomized distribution (p < 2.2  10–16). The
unavailability of ITRs at a given time may be related to local chro-
matin openness, cis- and trans-acting factors, cell cycle stage, or
other unknown elements of chromatin structure that have yet to
be explored. To address the variance of ITR frequencies and SETMAR
binding sites related to chromosome size, we plotted the number of
ITRs and SETMAR-HA peaks per chromosome as a function of chro-Fig. 6. Sequence fidelity of the ITR motif determines the affinity of SETMAR-HA bin
motif (0MM = 763, 1MM = 3104, 2MM = 3812, 3MM = 3175), and distribution of the ChIP
box) represents genomic background. There is a statistically significant difference betwe
rank sum test). ChIP-seq scores, related to the affinity of SETMAR-HA binding, are invers
ITR group. (B) Identification of critical ITR nucleotide positions for SETMAR’s chromatin b
HA for solo ITRs (sITR) are highlighted (position, mutation type, and frequency/% of cas
compared to 0MM sITR (p value < 10-6, Wilcoxon rank sum test). Number of cases: sITRs w
Rare events with a mutation frequency of<2% were excluded from the analysis. (C) Ann
regions. Percentage represents the proportion of 0-3MM ITRs within each annotation ca
4038mosome length (Fig. 5C). The results clearly show that the distribu-
tion of SETMAR-HA binding sites and ITR motifs was strongly
correlated with chromosome length and showed significant covari-
ation (Spearman r = 0.89; p < 0.001). The X chromosome is a notable
exception, as SETMAR binding sites did not correlate with ITR num-
bers and chromosome size. This unexpected behaviour of chromo-
some X awaits explanation. To identify critical nucleotide positions
in the core ITR motif that are required for SETMAR’s efficient chro-
matin binding, we grouped ITRs based on the number of mis-
matches in the 19nt 50-GGTGCAAAAGTAATTGCGG-30 sequence (0-
3MM groups, Supplementary Table S1) and plotted the SETMAR-
HA signal over the categories (Fig. 6). We found that ChIP-seq
scores, related to the affinity of SETMAR-HA binding, were inversely
proportional to the number ofmismatches in the ITRmotif (Fig. 6A),
i.e. the greater the number of mismatches, the lower the affinity of
SETMAR (p < 2.2 10-16). Furthermore, nucleotide positions G2, G4,
T14, C17, G18, G19 appeared to be essential for the association of
SETMAR and ITRs, as single-nucleotide changes in these bases sig-
nificantly reduced the affinity of SETMAR-HA binding (Fig. 6B).
Based on the degree of affinity loss and the prevalence of muta-
tional change, C-to-T and C-to-A transversions at position C17
proved to be the most critical mutations (change in affinity: greater
than4-fold; cumulative allele frequency: 33%). Compared to posi-
tion C17, G-to-A and G-to-Tmutations of G18were also widespread
(38%) but did not cause similar affinity changes, while G-to-Amuta-
tion of G2 and G4 led to a large decrease in affinity but were rareding. (A) ITRs were grouped based on the number of mismatches in the core 19 nt
signal was plotted over the categories (average ChIP-seq score per ITR). ‘‘Total” (grey
en groups and compared to genomic background (p value < 2.2  10-16, Wilcoxon
ely proportional to the number of mismatches. PWM logos are highlighted for each
inding. Single-nucleotide changes that significantly reduce the affinity of SETMAR-
es in the 1MM group). ChIP-seq scores show a significant reduction in each group
ith one mismatch (1MM sITR = 1519), sITRs with zero mismatch (0MM sITR = 322).
otation of ITR groups in intergenic and genic (exon, intron, TSS, TTS) chromosomal
tegory. TSS: transcription start site. TTS: transcription termination site.
Fig. 7. Gene expression values of SETMAR associated genes scale with the number of ITR mismatches. (A) Representative genes showing the reciprocal association of
mRNA expression level and ITR mismatch number. FPKM stands for Fragments Per Kilobase of transcript per Million mapped reads. (B) mRNA expression levels of SETMAR-
HA associated genes grouped by the number of mismatches in ITRs (MM0 = 132, MM1 = 145, MM2 = 29, random = 304). The high fidelity group (MM0) shows significantly
reduced mRNA expression levels compared to the random gene group (p-value = 7.5  10-4, Wilcoxon rank sum test).
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the ITR categories showed no difference in their genomic localiza-
tion (Fig. 6C). It is noteworthy that more than 60% of the identified
mutations were G-to-A and C-to-T changes that correspond to
‘‘clock-like” mutation signatures in the COSMIC database [34].
Clock-like mutations are known to form continuously in normal
(and cancerous) human cell types, generatingmutations at a steady
rate throughout the lifetime of cells [35]. Since many ITRs occur in
pairs along the chromosomes and onemotif is typically of high fide-
lity (0MM group), the neutral allele is free to mutate during evolu-
tion while the conserved motif can still bind and position SETMAR.
We found 454 paired ITRs of which 388 (85.4%) were 0MM/1-3MM
ITR pairs. In this way, clock-like ITR polymorphisms provide a ratio-
nale for fine-tuning SETMAR’s biological function related to tran-
scription. Accordingly, when SETMAR-associated genes were
grouped by the number of mismatches in the ITR motif, the high-
fidelity group (MM0) showed significantly reduced mRNA expres-
sion levels compared to the random gene group (Fig. 7). ITR
sequence fidelity was inversely proportional to gene expression
levels, i.e., the lower the number of ITR mismatches, the stronger
the repression of SETMAR-bound gene loci. The preferential associ-
ation of SETMAR and repressed genes is fully consistent with previ-
ous results [10], which provide strong evidence for SETMAR binding
to the most lowly expressed genes with FPKM values between zero
and one.4. Conclusions
The results presented in this study clearly show that SETMAR
preferentially targets Hsmar1 transposon ends (ITRs) in living cells4039that are dispersed throughout the human genome. In contrast to
previous studies, we could not detect any off-target binding events
at non-ITR sequences. Possible reasons for the differences may
include the use of different cell lines (U2OS osteosarcoma cells
vs. HAP1 lymphoblastic leukaemia cells), tags (FLAG vs. HA), NGS
platforms (SOLiD vs. Illumina), and the low NGS coverage of the
previous study [17]. In our experiment, SETMAR was bound to
the theoretically expected sequences [10] targeted by its trans-
posase domain. The probability that SETMAR binds to ITR
sequences by chance is extremely low (p-value < 2.2  10-16;
Fig. 4B). In addition, several ChIP peaks were validated by qPCR
in samples with and without doxycycline induction (Fig. 3 and
Supplementary Fig. S4), confirming the specificity of ChIP peak
detection.
In conclusion, sequence fidelity of the ITR motif has been iden-
tified as the only factor that determines the affinity of SETMAR to
chromosomes, such that higher ITR fidelity and increased SETMAR
chromatin binding resulted in stronger suppression of SETMAR-
bound gene loci. This mechanism may be part of a subtle evolu-
tionary strategy to fine-tune transcriptional processes regulated
by SETMAR.5. Key points
1. SETMAR/Metnase preferentially targets Hsmar1 transposon
ends (ITRs) in living cells
2. Sequence fidelity of the ITR motif determines the affinity of SET-
MAR/Metnase to chromosomes
3. Higher ITR fidelity results in increased affinity for chromatin
and stronger repression of SETMAR-bound gene loci
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